EMORY UNIVERSITY
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1836-12-10
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.emory.edu
THRIVE Breast Cancer App Study
- Conditions
- Breast Neoplasm Female
- Interventions
- Behavioral: THRIVE AppBehavioral: Tailored Feedback Messages
- First Posted Date
- 2018-07-19
- Last Posted Date
- 2023-09-05
- Lead Sponsor
- Emory University
- Target Recruit Count
- 304
- Registration Number
- NCT03592771
- Locations
- 🇺🇸
West Cancer Center, Midtown, Memphis, Tennessee, United States
🇺🇸West Cancer Center, East Memphis, Memphis, Tennessee, United States
Weight Loss Aid in an Exposed Population
- Conditions
- Polybrominated Biphenyl Poisoning
- Interventions
- First Posted Date
- 2018-07-11
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Emory University
- Target Recruit Count
- 100
- Registration Number
- NCT03582722
- Locations
- 🇺🇸
Michele Marcus, Atlanta, Georgia, United States
Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer
- Conditions
- Stage IB Intrahepatic Cholangiocarcinoma AJCC v8Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8Resectable CholangiocarcinomaStage IIIB Intrahepatic Cholangiocarcinoma AJCC v8Stage II Intrahepatic Cholangiocarcinoma AJCC v8Stage III Intrahepatic Cholangiocarcinoma AJCC v8
- Interventions
- First Posted Date
- 2018-07-09
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Emory University
- Target Recruit Count
- 31
- Registration Number
- NCT03579771
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸Emory University Hospital Midtown, Atlanta, Georgia, United States
Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer
- Conditions
- Stage IIB Gallbladder Cancer AJCC v8Stage I Gallbladder Cancer AJCC v8Stage II Gallbladder Cancer AJCC v8Stage IIA Gallbladder Cancer AJCC v8Stage III Gallbladder Cancer AJCC v8Stage IIIA Gallbladder Cancer AJCC v8Stage IIIB Gallbladder Cancer AJCC v8
- Interventions
- First Posted Date
- 2018-07-09
- Last Posted Date
- 2020-06-05
- Lead Sponsor
- Emory University
- Registration Number
- NCT03579758
- Locations
- 🇺🇸
Stanford Cancer Institute Palo Alto, Stanford, California, United States
🇺🇸Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸Emory University Hospital Midtown, Atlanta, Georgia, United States
Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell Disease
- Conditions
- Sickle Cell Disease
- Interventions
- Other: No training for use of web based Decision AidOther: Training for use of web based Decision AidOther: Pretest surveys and posttest surveysOther: Only posttest surveys
- First Posted Date
- 2018-07-05
- Last Posted Date
- 2019-07-23
- Lead Sponsor
- Emory University
- Target Recruit Count
- 2
- Registration Number
- NCT03577691
- Locations
- 🇺🇸
Grady Health System, Atlanta, Georgia, United States
🇺🇸Hughes Spalding Children's Hospital, Atlanta, Georgia, United States
🇺🇸Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer
- Conditions
- Human Papillomavirus Positive Oropharyngeal Squamous Cell CarcinomaStage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7
- Interventions
- First Posted Date
- 2018-07-02
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Emory University
- Registration Number
- NCT03575234
- Locations
- 🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸Emory University Hospital Midtown, Atlanta, Georgia, United States
Pre-exposure Prophylaxis (PrEP) at Home
- Conditions
- HIV/AIDS
- Interventions
- Behavioral: PrEP@Home SystemOther: Standard of Care
- First Posted Date
- 2018-06-26
- Last Posted Date
- 2024-05-10
- Lead Sponsor
- Emory University
- Target Recruit Count
- 318
- Registration Number
- NCT03569813
- Locations
- 🇺🇸
Washington University AIDS Clinical Trial Unit, Saint Louis, Missouri, United States
🇺🇸Emory University, PRISM Health, Atlanta, Georgia, United States
🇺🇸Open Arms Health Care Center, Jackson, Mississippi, United States
Improving Health-Promoting Behaviors in Adolescent Cancer Survivors Using AWAKE: A Feasibility Trial
- Conditions
- Health Behavior
- Interventions
- Behavioral: AWAKE
- First Posted Date
- 2018-06-21
- Last Posted Date
- 2021-12-08
- Lead Sponsor
- Emory University
- Target Recruit Count
- 92
- Registration Number
- NCT03564587
- Locations
- 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Cognitive Behavioral Therapy for African Americans With Uncontrolled Type-2 Diabetes
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Behavioral: Group-based Cognitive Behavioral InterventionBehavioral: Web-based Cognitive Behavioral InterventionBehavioral: Usual Care
- First Posted Date
- 2018-06-19
- Last Posted Date
- 2023-08-02
- Lead Sponsor
- Emory University
- Target Recruit Count
- 20
- Registration Number
- NCT03562767
- Locations
- 🇺🇸
Emory Dunwoody Clinic, Atlanta, Georgia, United States
Responses to Rabies Vaccine in Adults With or Without Antibiotics
- Conditions
- Rabies Human
- Interventions
- First Posted Date
- 2018-06-14
- Last Posted Date
- 2023-06-08
- Lead Sponsor
- Emory University
- Target Recruit Count
- 37
- Registration Number
- NCT03557008
- Locations
- 🇺🇸
Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
🇺🇸The Hope Clinic of the Emory Vaccine Center, Decatur, Georgia, United States